Article Sidebar

PDF
Date Published: 12/11/2024
Abstract Views: 13
Views PDF: 6
Issue
Vol. 3 No. 47 (2024): Tạp chí Truyền nhiễm Việt Nam
Section
Scientific research
How to Cite
Nguyen, M. T., Nguyen, H. N., Le, V. P. T., Nguyen, T. G. H., Phan, T. H., & Nguyen, P. H. (2024). MANAGEMENT OF HAND FOOT AND MOUTH DISEASE WITH SEVERE COMPLICATION. Vietnam Journal of Infectious Diseases, 3(47), 32-39. https://truyennhiemvietnam.vn/index.php/vjid/article/view/382

MANAGEMENT OF HAND FOOT AND MOUTH DISEASE WITH SEVERE COMPLICATION

Minh Tien Nguyen, Huu Nhan Nguyen, Vu Phuong Thy Le, Thi Gia Hanh Nguyen, Thanh Hong Phan, Phuoc Huu Nguyen

Main Article Content

Abstract

Objectives: To describe therapeutic interventions for children having hand foot mouth disease (HFMD)
with severe complication admitted at Emergency Department, Pediatric Intensive Care Unit, City Children’s hospital from May 2023 till September 2023.
Methods: Retrospective case series study.
Results and conclusions: 148 HFMD with severe complication consisted of grade 3 (74.3%), grade 4
(25.7%), mean age of 22.4 months old, most of them under 3 years (90.5%). Respiratory complication
requiring mechanical ventilation accounted for 70.3%, cardiovascular complication included cardiopulmonary collapse (14.2%), systemic arterial hypertension (35.1%). Management of HFMD with severe complication composed of early mechanical ventilation, shock resuscitation by approved standard
flowchart and continuous veno-venous hemofiltration. Average length of stay in PICU was 6.3 days, 2 case
died (1.4%) in condition of refractory shock, respiratory failure and deep coma. 
Recommendations: Modern medical instruments for respiratory, circulatory resuscitation should be equipped for province hospitals as well as high techniques such as mechanical ventilation, monitor of IBP, should be handed over in order to save more children with HFMD with severe complication.

Article Details

Keywords

Hand Foot Mouth Disease, severe complication

References

1. Bộ Y tế, Hướng dẫn chẩn đoán và điều trị bệnh tay chân miệng, 19/07/2012, tr.1-3.
2. K. Makonkawkeyoon, T. Sudjaritruk, V. Sirisanthana, Fulminant enterovirus 71 infection: case report, Annals of Tropical Paediatrics (2010) 30, 245-248.
3. Lin TY, Chang LY, Huang YC, Hsu KH,Chiu CH, Yang KD. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta. Paediatr. 91, 632-635 (2002).
4. Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis.36, 269-274 (2003).
5. Mong How Ooi, See Chang Wong, Penny Lewthwaite, Mary Jane Cardosa, Tom Solomon, Clinical features, diagnosis, and management of enterovirus 71, The Lancet, Vol 9 November 1097-1102 (2010).
6. Shih-Min Wang, Ching-Chuan Liu. Enterovirus 71: epidemiology, pathogenesis and management, Expert Rev. Anti-infect. Ther. 7(6), 735-742 (2009).
7. Wang SM, Lei HY, Huang KJ et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: the roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 188, 564-570 (2003).
8. Wang SM, Lei HY, Yu CK et al. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J. Infect. Dis. 198, 1002-1006 (2008).
9. Wang SM, Lei HY, Huang MC et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J. Clin. Virol. 37, 47-52 (2006).
10. Wang SM, Lei HY, Huang MC et al. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr. Pulmonol. 39, 219-223 (2005).